|
MTHFD1L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.84429948879972E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.55989999595496E-08 |
| Normal-vs-Stage2 |
3.05560000002369E-06 |
| Normal-vs-Stage3 |
8.615100E-04 |
| Normal-vs-Stage4 |
1.558540E-03 |
| Stage1-vs-Stage2 |
2.995600E-01 |
| Stage1-vs-Stage3 |
3.590000E-01 |
| Stage1-vs-Stage4 |
1.092620E-01 |
| Stage2-vs-Stage3 |
9.279200E-01 |
| Stage2-vs-Stage4 |
4.570000E-01 |
| Stage3-vs-Stage4 |
6.393400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.38600003590983E-09 |
| Normal-vs-AfricanAmerican |
4.34310000185789E-08 |
| Normal-vs-Asian |
2.933400E-01 |
| Caucasian-vs-AfricanAmerican |
1.921840E-01 |
| Caucasian-vs-Asian |
4.414800E-01 |
| AfricanAmerican-vs-Asian |
3.088200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.82180000477084E-08 |
| Normal-vs-Female |
6.75069999900302E-11 |
| Male-vs-Female |
2.118500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.211199999962E-06 |
| Normal-vs-Extreme_Weight |
3.23079999975384E-07 |
| Normal-vs-Obese |
1.41849999524268E-08 |
| Normal-vs-Extreme_Obese |
2.247200E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.187360E-01 |
| Normal_Weight-vs-Obese |
9.861400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.801040E-03 |
| Extreme_Weight-vs-Obese |
6.399700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.603600E-02 |
| Obese-vs-Extreme_Obese |
8.192700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.217100E-03 |
| Normal-vs-Age(41-60Yrs) |
7.81389952742018E-10 |
| Normal-vs-Age(61-80Yrs) |
1.59599999882687E-08 |
| Normal-vs-Age(81-100Yrs) |
4.827900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.563030E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.274200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.462100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.243200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.570200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.209390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.05200004263395E-09 |
| Normal-VS-Type2 PRCC |
6.14270000000028E-05 |
| Normal-VS-KIRP CIMP |
1.045920E-04 |
| Normal-VS-Unclassified PRCC |
1.95747999999218E-05 |
| Type1 PRCC-VS-Type2 PRCC |
3.753900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.367300E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
6.760800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.044100E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.878000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.002500E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.623660E-04 |
| Normal-vs-N1 |
1.574950E-04 |
| Normal-vs-N2 |
1.043640E-04 |
| N0-vs-N1 |
2.165800E-02 |
| N0-vs-N2 |
4.179700E-02 |
| N1-vs-N2 |
9.492800E-01 |
|
|
